Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline

Respiratory Medicine

Volumn 108, Issue 7, 2014, Pages 976-982

  Matsunaga, Kazuto ^a   Ichikawa, Tomohiro ^a   Oka, Asako ^a   Morishita, Yukiko ^a   Kanai, Kuninobu ^a   Hiramatsu, Masataka ^a   Akamatsu, Hiroaki ^a   Kawabata, Hiroki ^a   Kikuchi, Takashi ^a   Akamatsu, Keiichiro ^a   Hirano, Tsunahiko ^a   Kou, Yasuhiro ^a   Nakanishi, Masanori ^a   Minakata, Yoshiaki ^a   Yamamoto, Nobuyuki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Airway inflammation; Airway obstruction; Airway remodeling; Asthma exacerbation; Inhaled corticosteroids; Lung function

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE; BRONCHODILATING AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; ASTHMA; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NITRIC OXIDE ANALYZER; PATIENT CODING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STANDARD; DISEASE COURSE; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; BRONCHODILATOR AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAL CAPACITY;

EID: 84902370223     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.04.014     Document Type: Article

References (28)

1. Global Initiative for Asthma Global strategy for asthma management and prevention Workshop report 2006 NHLBI/WHO
2. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, and R.A. Pauwels et al. Can guideline-defined control be achieved? The Gaining Optimal Asthma Control study Am J Respir Crit Care Med 170 2004 836 844
3. B. Lundback, E. Ronmark, A. Lindberg, J.C. Jonsson, L.G. Larsson, and M. James Asthma control over 3 years in a real-life study Respir Med 103 2009 348 355
4. K. Matsunaga, H. Kawabata, T. Hirano, H. Sugiura, Y. Minakata, and M. Ichinose Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol Pulm Pharamcol Ther 26 2013 189 194
5. C.S. Murray Can inhaled corticosteroids influence the natural history of asthma? Curr Opin Allergy Clin Immunol 8 2008 77 81
6. P. Lange, J. Parner, J. Vestbo, P. Schnohr, and G. Jensen A 15-year follow-up study of ventilator function in adults with asthma N Engl J Med 339 1998 1194 1200
7. R.A. Covar, J.D. Spahn, J.R. Murphy, and S.J. Szefler Progression of asthma measured by lung function in the childhood asthma management program Am J Respir Crit Care Med 170 2004 234 241
8. P.M. O'Byrne, S. Pederson, C.J. Lamm, W.C. Tan, and W.W. Busse Severe exacerbations and decline in lung function in asthma Am J Respir Crit Care Med 179 2009 19 24
9. P. Lange, H. Scharling, C.S. Ulrik, and J. Vestbo Inhaled corticosteroids and decline of lung function in community residents with asthma Thorax 61 2006 100 104
10. K. Matsunaga, K. Akamatsu, A. Miyatake, and M. Ichinose Natural history and risk factors of obstructive changes over a 10-year period in severe asthma Respir Med 107 2013 355 360
11. J.H. Lee, T. Haselkorn, L. Borish, L. Rasoouliyan, B.E. Chipps, and S.E. Wenzel Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study Chest 132 2007 1882 1889
12. I.H. van Veen, A. Ten Brinke, P.J. Sterk, J.K. Sont, S.A. Gauw, and K.F. Rabe et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Eur Respir J 32 2008 344 349
13. K. Matsunaga, T. Hirano, K. Akamatsu, and Y. Minakata Predictors for identifying the efficacy of systemic steroids on sustained exhaled nitric oxide elevation in severe asthma Allergol Int 62 2013 359 365
14. K. Matsunaga, S. Yanagisawa, T. Hirano, T. Ichikawa, A. Koarai, and K. Akamatsu et al. Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics Clin Exp Allergy 42 2012 775 781
15. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update Allergy 63 Suppl. 86 2008 8 160
16. American College of Gastroenterology Updated guidelines for the diagnosis and treatment of gastroesophageal reflex disease Am J Gastroenterol 100 2005 190 200
17. K. Matsunaga, T. Hirano, T. Kawayama, T. Tsuburai, H. Nagase, and H. Aizawa et al. Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population Allergol Int 59 2010 363 367
18. T. Shirai, K. Furuhashi, T. Suda, and K. Chida Relationship of the asthma control test with pulmonary function and exhaled nitric oxide Ann Allergy Asthma Immunol 101 2008 608 613
19. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, and W.W. Busse et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations Am J Respir Crit Care Med 180 2009 59 99
20. G.E. Silva, D.L. Sherrill, S. Guerra, and R.A. Barbee Asthma as a risk factor for COPD in a longitudinal study Chest 126 2004 59 65
21. C.C. Van Diemen, D.S. Postma, J.M. Vonk, M. Bruinenberg, J.P. Schouten, and H.M. Boezen A disintegrin and metalloprotease 33 polymorphisms and ling function decline in the general population Am J Respir Crit Care Med 172 2005 329 333
22. A. Dijkstra, J.M. Vonk, H. Jongepier, G.H. Koppeleman, J.P. Schouten, and N.H. ten Hacken et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex Thorax 61 2006 105 110
23. R.M. Pascual, and S.P. Peters Airway remodeling contributes to the progressive loss of lung function in asthma: an overview J Allergy Clin Immunol 116 2005 477 486
24. S.T. Holgate, J. Holloway, and S. Wilson Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities J Allergy Clin Immunol 117 2006 496 506
25. T.R. Bai, J.M. Vonk, D.S. Postma, and H.M. Boezen Severe exacerbations predict excess lung function decline in severe asthma Eur Respir J 30 2007 452 456
26. C.L. Grainge, L.C. Lau, J.A. Ward, V. Dulay, G. Lahiff, and S. Wilson et al. Effect of bronchoconstriction on airway remodeling in asthma N Engl J Med 364 2011 2006 2015
27. J.A. Park, and D.J. Tschumperlin Chronic intermittent mechanical stress increases MUC5AC protein expression Am J Respir Cell Mol Biol 41 2009 459 466
28. M. Contoli, S. Baraldo, B. Marku, P. Casolari, J.A. Marwick, and G. Turato et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up J Allergy Clin Immunol 125 2010 830 837